rs876657650
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_170707.4(LMNA):c.476delA(p.Glu159GlyfsTer18) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. E159E) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_170707.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMNA | NM_170707.4 | c.476delA | p.Glu159GlyfsTer18 | frameshift_variant | Exon 2 of 12 | ENST00000368300.9 | NP_733821.1 | |
LMNA | NM_005572.4 | c.476delA | p.Glu159GlyfsTer18 | frameshift_variant | Exon 2 of 10 | ENST00000677389.1 | NP_005563.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMNA | ENST00000368300.9 | c.476delA | p.Glu159GlyfsTer18 | frameshift_variant | Exon 2 of 12 | 1 | NM_170707.4 | ENSP00000357283.4 | ||
LMNA | ENST00000677389.1 | c.476delA | p.Glu159GlyfsTer18 | frameshift_variant | Exon 2 of 10 | NM_005572.4 | ENSP00000503633.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Primary dilated cardiomyopathy Pathogenic:1
The p.Glu159fs variant in LMNA has not been previously reported in individuals w ith cardiomyopathy or in large population studies. This variant is predicted to cause a frameshift, which alters the protein?s amino acid sequence beginning at position 159 and leads to a premature termination codon 18 amino acids downstrea m. This alteration is then predicted to lead to a truncated or absent protein. H eterozygous loss of LMNA function is an established disease mechanism in individ uals with DCM +/- conduction system defects. In summary, although additional stu dies are required to fully establish its clinical significance, the p.Glu159fs v ariant is likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at